|
Centers for Disease
Control and Prevention
Division of Cancer
Prevention and Control
4770 Buford Hwy, NE
MS K-64
Atlanta, GA 30341-3717
Call: 1 (800) CDC-INFO
TTY: 1 (888) 232-6348
FAX: (770) 488-4760
E-mail: cdcinfo@cdc.gov
Submit a Question Online
|
|
|
|
Sharing the Decision Slide Set:
Index View
Terms of Use: This CDC slide set is in the public domain. You may reproduce these slides without permission as long as they are not changed in any way. However, if you wish to adapt and/or revise these slides, you must remove the CDC name, logo, and any other references prior to use. Failure to follow these procedures could result in legal action.
- Screening for Prostate Cancer: Sharing the Decision
- These Organizations Recommend a Form of Shared Decision Making for Prostate Cancer Screening
- Today's Goals
- Goal 1: Discuss What Is Known about the Risk of Prostate Cancer and Its Natural History
- Risk of Prostate Cancer in 40 Year Old U.S. Men, to End of Life (per 1,000 Men)
- Risk of Death for 40 Year Old U.S. Men, to End of Life, by Leading Causes
- Prostate Cancer Trends in Incidence and Mortality, 1973–1999
- Risk of Death from Prostate Cancer by Age and Race/Ethnicity
- Risk of Prostate Cancer Diagnosis by Age and Race/Ethnicity
- Natural History of Prostate Cancer
- Prostate Cancers Vary in Their Natural Histories
- Preventing Prostate Cancer
- Summary
- Goal 2: Discuss the Benefits and Harms of Prostate Cancer Screening and Treatment
- Key Issues of Screening and Early Treatment
- What Are the Potential Benefits of Screening?
- Prostate Cancer Incidence Rates by Stage, 1973–1995
- Finding Prostate Cancer Earlier Is Not Enough
- Can We Treat Early-Stage Prostate Cancer Effectively?
- Risk of Mortality from Prostate Cancer Among Men in a Randomized Trial
- What Happened to U.S. Prostate Cancer Mortality Rates as Screening Rates Increased?
- What Happens to Prostate Cancer Mortality Rates in the U.K., Where PSA Screening Is Rare?
- Do We Extend Men's Lives by Screening for Prostate Cancer?
- Are There Harms from Screening and Early Treatment?
- Harms: False Positives
- Overdiagnosis
- Overdiagnosis, Tumor Heterogeneity, and Life Expectancy
- Overdiagnosis
- Tumor Rates by Grade
- Side Effects of Treatment
- Summary
- How Can I Decide Whether to Screen My Patients?
- Should I Screen Higher-Risk Patients?
- Goal 3: Discuss How Clinicians Can Use Shared Decision Making to Help Patients Decide Whether to Be Screened for Prostate Cancer
- Informing Patients
- Adding Shared Decision Making
- Shared Decision Making for Other Clinical Decisions
- Benefits of Shared Decision Making
- What Is the Best Way to Use Shared Decision Making?
- Inform Your Patient
- Decision Aids to Help in Shared Decision Making
- Decision Aids to Help in Shared Decision Making
- Discuss His Questions and Concerns
- Discuss Why Men Choose Different Options
- Listen and Make a Joint Decision
- Summary
- CDC Activities and Resources Related to Prostate Cancer and Shared Decision Making
|
|